Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -18.443\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a CC1CCN(C(=O)/C(=C\c2ccccc2F)NC(=O)c2ccccc2)CC1
b CCOC(=O)[C@H]1[C@H]2COc3cc(OC)ccc3[C@@H]2N2C(=O)N(c3ccc(Br)cc3)C(=O)[C@@]12C
Answer: a. CC1CCN(C(=O)/C(=C\c2ccccc2F)NC(=O)c2ccccc2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCN(C(=O)/C(=C\c2ccccc2F)NC(=O)c2ccccc2)CC1
CC1CCN(C(=O)/C(=C\c2ccccc2F)NC(=O)c2ccccc2)CC1
N-[(E)-1-(2-fluorophenyl)-3-(4-methylpiperidin-1-yl)-3-oxoprop-1-en-2-yl]benzamide